BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 12042822)

  • 1. Dyskinesias following neural transplantation in Parkinson's disease.
    Hagell P; Piccini P; Björklund A; Brundin P; Rehncrona S; Widner H; Crabb L; Pavese N; Oertel WH; Quinn N; Brooks DJ; Lindvall O
    Nat Neurosci; 2002 Jul; 5(7):627-8. PubMed ID: 12042822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
    Freed CR; Greene PE; Breeze RE; Tsai WY; DuMouchel W; Kao R; Dillon S; Winfield H; Culver S; Trojanowski JQ; Eidelberg D; Fahn S
    N Engl J Med; 2001 Mar; 344(10):710-9. PubMed ID: 11236774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia.
    Carlsson T; Winkler C; Lundblad M; Cenci MA; Björklund A; Kirik D
    Neurobiol Dis; 2006 Mar; 21(3):657-68. PubMed ID: 16256359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants.
    Politis M; Wu K; Loane C; Quinn NP; Brooks DJ; Rehncrona S; Bjorklund A; Lindvall O; Piccini P
    Sci Transl Med; 2010 Jun; 2(38):38ra46. PubMed ID: 20592420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective.
    Hagell P; Cenci MA
    Brain Res Bull; 2005 Dec; 68(1-2):4-15. PubMed ID: 16324999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease.
    Lane EL; Brundin P; Cenci MA
    Neurobiol Dis; 2009 Jul; 35(1):42-51. PubMed ID: 19361557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting the clinical outcome after neural transplantation in Parkinson's disease.
    Piccini P; Pavese N; Hagell P; Reimer J; Björklund A; Oertel WH; Quinn NP; Brooks DJ; Lindvall O
    Brain; 2005 Dec; 128(Pt 12):2977-86. PubMed ID: 16246865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease.
    Lane EL; Soulet D; Vercammen L; Cenci MA; Brundin P
    Neurobiol Dis; 2008 Nov; 32(2):220-8. PubMed ID: 18675359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease.
    Brundin P; Pogarell O; Hagell P; Piccini P; Widner H; Schrag A; Kupsch A; Crabb L; Odin P; Gustavii B; Björklund A; Brooks DJ; Marsden CD; Oertel WH; Quinn NP; Rehncrona S; Lindvall O
    Brain; 2000 Jul; 123 ( Pt 7)():1380-90. PubMed ID: 10869050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants.
    Sawle GV; Bloomfield PM; Björklund A; Brooks DJ; Brundin P; Leenders KL; Lindvall O; Marsden CD; Rehncrona S; Widner H
    Ann Neurol; 1992 Feb; 31(2):166-73. PubMed ID: 1575455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon.
    Peschanski M; Defer G; N'Guyen JP; Ricolfi F; Monfort JC; Remy P; Geny C; Samson Y; Hantraye P; Jeny R
    Brain; 1994 Jun; 117 ( Pt 3)():487-99. PubMed ID: 8032859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyskinesias after neural transplantation in Parkinson's disease: what do we know and what is next?
    Politis M
    BMC Med; 2010 Dec; 8():80. PubMed ID: 21126348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease.
    Lindvall O; Sawle G; Widner H; Rothwell JC; Björklund A; Brooks D; Brundin P; Frackowiak R; Marsden CD; Odin P
    Ann Neurol; 1994 Feb; 35(2):172-80. PubMed ID: 8109898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases.
    Mendez I; Dagher A; Hong M; Gaudet P; Weerasinghe S; McAlister V; King D; Desrosiers J; Darvesh S; Acorn T; Robertson H
    J Neurosurg; 2002 Mar; 96(3):589-96. PubMed ID: 11883846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patients.
    Levivier M; Dethy S; Rodesch F; Peschanski M; Vandesteene A; David P; Wikler D; Goldman S; Claes T; Biver F; Liesnard C; Goldman M; Hildebrand J; Brotchi J
    Stereotact Funct Neurosurg; 1997; 69(1-4 Pt 2):99-111. PubMed ID: 9711741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesia in parkinsonian rats.
    Steece-Collier K; Collier TJ; Danielson PD; Kurlan R; Yurek DM; Sladek JR
    Mov Disord; 2003 Dec; 18(12):1442-54. PubMed ID: 14673880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient.
    Kordower JH; Goetz CG; Chu Y; Halliday GM; Nicholson DA; Musial TF; Marmion DJ; Stoessl AJ; Sossi V; Freeman TB; Olanow CW
    Ann Neurol; 2017 Jan; 81(1):46-57. PubMed ID: 27900791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease.
    Kordower JH; Freeman TB; Chen EY; Mufson EJ; Sanberg PR; Hauser RA; Snow B; Olanow CW
    Mov Disord; 1998 May; 13(3):383-93. PubMed ID: 9613726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease.
    Wenning GK; Odin P; Morrish P; Rehncrona S; Widner H; Brundin P; Rothwell JC; Brown R; Gustavii B; Hagell P; Jahanshahi M; Sawle G; Björklund A; Brooks DJ; Marsden CD; Quinn NP; Lindvall O
    Ann Neurol; 1997 Jul; 42(1):95-107. PubMed ID: 9225690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyskinesias after transplantation in Parkinson's disease.
    Piccini P
    Lancet Neurol; 2002 Dec; 1(8):472. PubMed ID: 12849327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.